{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T06:31:32Z","timestamp":1784874692614,"version":"3.55.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.ijcard.2011.05.056","type":"journal-article","created":{"date-parts":[[2011,6,19]],"date-time":"2011-06-19T05:39:52Z","timestamp":1308461992000},"page":"112-116","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["A clinical risk score for heart failure in patients with type 2 diabetes and macrovascular disease: An analysis of the PROactive study"],"prefix":"10.1016","volume":"162","author":[{"given":"Roman","family":"Pfister","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Cairns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erland","family":"Erdmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian A.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2011.05.056_bb0005","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1161\/01.CIR.0000054165.93055.42","article-title":"Prevention of Heart Failure in Patients in the Heart Outcomes Prevention Evaluation (HOPE) Study","volume":"107","author":"Arnold","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2011.05.056_bb0010","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.2337\/diacare.27.8.1879","article-title":"The incidence of congestive heart failure in type 2 diabetes: an update","volume":"27","author":"Nichols","year":"2004","journal-title":"Diab Care"},{"key":"10.1016\/j.ijcard.2011.05.056_bb0015","doi-asserted-by":"crossref","first-page":"699","DOI":"10.2337\/diacare.27.3.699","article-title":"Heart failure prevalence, incidence, and mortality in the elderly with diabetes","volume":"27","author":"Bertoni","year":"2004","journal-title":"Diab Care"},{"key":"10.1016\/j.ijcard.2011.05.056_bb0020","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1161\/CIRCHEARTFAILURE.108.768457","article-title":"Incident heart failure prediction in the elderly: the health ABC heart failure score","volume":"1","author":"Butler","year":"2008","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.ijcard.2011.05.056_bb0025","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1001\/archinte.159.11.1197","article-title":"Profile for estimating risk of heart failure","volume":"159","author":"Kannel","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ijcard.2011.05.056_bb0030","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.2337\/diacare.24.9.1614","article-title":"Congestive heart failure in type 2 diabetes: prevalence, incidence, and risk factors","volume":"24","author":"Nichols","year":"2001","journal-title":"Diab Care"},{"key":"10.1016\/j.ijcard.2011.05.056_bb0035","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1093\/eurheartj\/ehp604","article-title":"Heart failure events with rosiglitazone in type 2 diabetes: data from the RECORD clinical trial","volume":"31","author":"Komajda","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ijcard.2011.05.056_bb0040","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1016\/j.amjcard.2005.07.061","article-title":"Hospitalizations for new heart failure among subjects with diabetes mellitus in the RENAAL and LIFE studies","volume":"96","author":"Carr","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ijcard.2011.05.056_bb0045","doi-asserted-by":"crossref","first-page":"855","DOI":"10.2337\/diacare.26.3.855","article-title":"Development of congestive heart failure in type 2 diabetic patients with microalbuminuria or proteinuria: observations from the DIABHYCAR (type 2 DIABetes, Hypertension, CArdiovascular Events and Ramipril) study","volume":"26","author":"Vaur","year":"2003","journal-title":"Diab Care"},{"key":"10.1016\/j.ijcard.2011.05.056_bb0050","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/bmj.321.7258.405","article-title":"Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study","volume":"321","author":"Stratton","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.ijcard.2011.05.056_bb0055","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/S0140-6736(05)67528-9","article-title":"Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial","volume":"366","author":"Dormandy","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2011.05.056_bb0060","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.2337\/diacare.27.7.1647","article-title":"The prospective pioglitazone clinical trial in macrovascular events (PROactive): can pioglitazone reduce cardiovascular events in diabetes? Study design and baseline characteristics of 5238 patients","volume":"27","author":"Charbonnel","year":"2004","journal-title":"Diab Care"},{"key":"10.1016\/j.ijcard.2011.05.056_bb0065","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.2337\/dc07-0717","article-title":"Pioglitazone use and heart failure in patients with type 2 diabetes and preexisting cardiovascular disease: data from the PROactive study (PROactive 08)","volume":"30","author":"Erdmann","year":"2007","journal-title":"Diab Care"},{"key":"10.1016\/j.ijcard.2011.05.056_bb0070","doi-asserted-by":"crossref","first-page":"e241","DOI":"10.1161\/CIRCULATIONAHA.108.191096","volume":"119","author":"Rautaharju","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2011.05.056_bb0075","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.jacc.2008.12.013","volume":"53","author":"Surawicz","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijcard.2011.05.056_bb0080","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/0002-9149(92)90562-D","article-title":"An improved method for adjusting the QT interval for heart rate (the Framingham Heart Study)","volume":"70","author":"Sagie","year":"1992","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ijcard.2011.05.056_bb0085","doi-asserted-by":"crossref","first-page":"5512","DOI":"10.1002\/sim.3148","article-title":"Selection of important variables and determination of functional form for continuous predictors in multivariable model building","volume":"26","author":"Sauerbrei","year":"2007","journal-title":"Stat Med"},{"key":"10.1016\/j.ijcard.2011.05.056_bb0090","series-title":"Applied survival analysis","author":"Hosmer","year":"1999"},{"key":"10.1016\/j.ijcard.2011.05.056_bb0095","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4","article-title":"Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors","volume":"15","author":"Harrell","year":"1996","journal-title":"Stat Med"},{"key":"10.1016\/j.ijcard.2011.05.056_bb0100","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3904\/kjim.2004.19.3.171","article-title":"Incidence of and risk factors for bundle branch block in adults older than 40years","volume":"19","author":"Jeong","year":"2004","journal-title":"Korean J Intern Med"},{"key":"10.1016\/j.ijcard.2011.05.056_bb0105","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1136\/hrt.2003.029553","article-title":"National survey of the prevalence, incidence, primary care burden, and treatment of heart failure in Scotland","volume":"90","author":"Murphy","year":"2004","journal-title":"Heart"},{"key":"10.1016\/j.ijcard.2011.05.056_bb0110","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1056\/NEJM199209033271003","article-title":"Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. The SOLVD Investigattors","volume":"327","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2011.05.056_bb0115","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1056\/NEJMoa0802743","article-title":"Effects of intensive glucose lowering in type 2 diabetes","volume":"358","author":"Gerstein","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2011.05.056_bb0120","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1002\/pds.1802","article-title":"Trends in the prescription of anti-diabetic medications in the United Kingdom: a population-based analysis","volume":"18","author":"Filion","year":"2009","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.ijcard.2011.05.056_bb0125","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1016\/j.jacc.2010.02.014","article-title":"Thiazolidinedione drugs and cardiovascular risks: a science advisory from the American Heart Association and American College of Cardiology Foundation","volume":"55","author":"Kaul","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijcard.2011.05.056_bb0130","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1016\/j.jacc.2006.10.077","article-title":"A randomized, placebo-controlled trial assessing the effects of rosiglitazone on echocardiographic function and cardiac status in type 2 diabetic patients with New York Heart Association Functional Class I or II Heart Failure","volume":"49","author":"Dargie","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijcard.2011.05.056_bb0135","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0140-6736(07)60106-8","article-title":"Adjudication of serious heart failure in patients from PROactive","volume":"369","author":"Ryden","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2011.05.056_bb0140","article-title":"Adjudication of serious heart failure in patients with type 2 diabetes and cardiovascular disease: results from PROactive","volume":"114","author":"Thrainsdottir","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2011.05.056_bb0145","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1001\/jama.292.3.344","article-title":"Trends in heart failure incidence and survival in a community-based population","volume":"292","author":"Roger","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2011.05.056_bb0150","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/S0140-6736(02)08358-7","article-title":"Screening for and treating left-ventricular abnormalities in diabetes mellitus: a new way of reducing cardiac deaths","volume":"359","author":"Struthers","year":"2002","journal-title":"Lancet"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527311004694?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527311004694?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T20:31:59Z","timestamp":1759091519000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527311004694"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S0167527311004694"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2011.05.056","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A clinical risk score for heart failure in patients with type 2 diabetes and macrovascular disease: An analysis of the PROactive study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2011.05.056","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}